Llwytho...
Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
Aromatase inhibitors (AI) are extensively used in the treatment of estrogen receptor-positive breast cancers, however resistance to AI treatment is commonly observed. Apart from Estrogen receptor (ERα) expression, no predictive biomarkers for response to AI treatment are clinically applied. Yet, sin...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Genom Data |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4536071/ https://ncbi.nlm.nih.gov/pubmed/26484094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2014.06.023 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|